Natus Medical Price Prediction and Hype Density Breakdown

BABY -- USA Stock  

USD 34.45  0.45  1.29%

We analyze noise-free headlines and recent hype associated with Natus Medical Incorporated which may create opportunities for some arbitrage if properly timed. With Natus Medical hype-based prediction module you can estimate the value of Natus Medical Incorporated from the prospective of Natus Medical response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Natus Medical over a specific investment horizon. Check also Natus Medical Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

Natus Medical After-Hype Price Density Analysis

 Next price density 
Expected price to next headline

Natus Medical Estimiated After-Hype Price Volatility

September 25, 2018
Current Value
After-hype Price
Target Odds
Natus Medical is not very risky asset. Analysis and calculation of next after-hype price of Natus Medical Incorp is based on 1 month time horizon.

Natus Medical Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.22% 3.68% 0.17%  0.02% 3 Events / Month4 Events / MonthIn about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Natus Medical Hype Timeline

Natus Medical Incorporated is currently traded for34.45. This company has historical hype elasticity of 0.17 and average elasticity to hype of competition of -0.02. Natus Medical Incorporated is projected to increase in value after the next headline with price going to jump to 34.62. The average volatility of media hype impact on the company stock price is about 490.67%. The price appreciation on the next news is anticipated to be 0.49% where as daily expected return is currently at -0.22%. The volatility of related hype on Natus Medical is about 4884.52% with expected price after next announcement by competition of 34.43. The company reported previous year revenue of 513.34 M. Net Loss for the year was (21.33 M) with profit before overhead, payroll, taxes, and interest of 287.59 M. Given the investment horizon of 30 days, the next projected press release will be in about 3 days.
Check also Natus Medical Basic Forecasting Models to cross-verify your projections.

Natus Medical Related Hype Analysis

At Risk
Edwards Lifesciences Corporation 0.18 7 per month 0.00  0.32  1.90 (1.28)  3.12 
Digirad Corporation(0.10) 5 per month 0.00 (0.25)  4.41 (5.56)  17.22 
Dynatronics Corporation(0.20) 4 per month 5.38  0.0036  7.41 (9.43)  22.02 
Encision 0.11 1 per month 10.30 (0.0128)  12.61 (16.68)  38.07 
Echo Therapeutics(0.0033) 2 per month 21.38  0.07  61.29 (38.00)  100.49 
EDAP TMS S A 0.02 1 per month 0.00 (0.18)  3.63 (3.85)  9.48 
Electromed 0.0399 2 per month 3.01  0.11  9.26 (4.31)  23.09 
Escalon Medical Corp 0.03 1 per month 15.46  0.12  27.07 (32.00)  74.66 
Establishment Labs Holdings(0.92) 4 per month 0.00 (0.13)  2.57 (4.32)  15.80 
Second Sight Medical Products 0.09 5 per month 2.42  0.14  6.36 (3.80)  11.42 

Contributor Headline

Latest Prospective on Natus Medical

Investors are also interested in

Purchased a lot of shares
Active 3 days ago
Purchased a lot of shares
Active 3 days ago
Purchased over 300 shares
Active 3 days ago
Purchased over 40 shares
Active 3 days ago
Purchased over 70 shares
Active 3 days ago
Check also Natus Medical Basic Forecasting Models to cross-verify your projections. Please also try Premium Stories module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.